Results 21 to 30 of about 5,342 (246)

RETRACTION: <b>Comparison of the Effect of Dydrogesterone and Natural Micronized Progesterone for Luteal-Phase Support in Assisted Reproductive Technology Cycles: A Single-Blind Randomized Clinical Trial Study</b>. [PDF]

Health Sci Rep
RETRACTION: M. Atarieh, M. Javadian, Z. Basirat, M. Kashifard, S. Yazdani, H. Adib‐Rad, M. Abdollahzade‐Delavar, and H. Gholinia, Health Science Reports 7, no. 8 (2024): e2296. https://doi.org/10.1002/hsr2.2296. The above article, published online on 08 August 2024 in Wiley Online Library (wileyonlinelibrary.com), and has been retracted by agreement ...
europepmc   +2 more sources

Endometriosis: impact on fertility and pregnancy outcomes

Гинекология, 2021
Aim. To investigate the modern condition of the problem of infertility and obstetric complications in endometriosis and the main management aspects of women with endometriosis in pregnancy planning. Materials and methods.
Rushania I. Gabidullina, Ekaterina A. Koshelnikova, Tatiana N. Shigabutdinova, Evgenii A. Melnikov, Gulfiria N. Kalimullina, Angelina I. Kuptsova   +5 more
doaj   +1 more source

Effect of Vaginal Progesterone and Dydrogesterone on Pregnancy Outcomes in patients with Threatened Abortion: A Randomized Clinical Trial [PDF]

Majallah-i Zanān, Māmā̓ī va Nāzā̓ī-i Īrān, 2021
Introduction: Despite the positive evidence on the effect of progesterone on protection of pregnancy in patients with threatened abortion, the results of studies regarding its drug type have been controversial.
Hamideh Pakniat, Iman Ansari, Nooshin Kashanipour, Farideh Movahed   +3 more
doaj   +1 more source

Supplementary dydrogesterone is beneficial as luteal phase support in artificial frozen-thawed embryo transfer cycles compared to micronized progesterone alone

Frontiers in Endocrinology, 2023
IntroductionThe number of frozen embryo transfers increased substantially in recent years. To increase the chances of implantation, endometrial receptivity and embryo competency must be synchronized.
Angela Vidal, Carolin Dhakal, Nathalie Werth, Jürgen Michael Weiss, Dirk Lehnick, Alexandra Sabrina Kohl Schwartz, Alexandra Sabrina Kohl Schwartz   +6 more
doaj   +1 more source

Hormonal parameters and embryological outcomes of in vitro fertilisation/intra cytoplasmic sperm injection cycles in women using dydrogesterone for the prevention of premature luteinizing hormone surge during ovarian stimulation [PDF]

Гинекология, 2022
Aim. To evaluate the hormonal parameters and embryological outcomes of an ovarian stimulation protocol using dydrogesterone to prevent the premature LH surge in IVF/ICSI programmes. Materials and methods.
Irina E. Korneeva, Alla I. Kovalchuk, Tatiana A. Nazarenko, Elena V. Mityurina, Svetlana G. Perminova, Aleksei V. Bachurin, Tatiana Yu. Ivanets   +6 more
doaj   +1 more source

Progestogen therapy in threatened miscarriage and unexplained recurrent pregnancy loss: Recommendations by the Thai interest group [PDF]

J Obstet Gynaecol Res
Abstract Aim Threatened miscarriage and unexplained recurrent pregnancy loss (RPL) pose significant physical and psychological challenges for women and their families globally. The lack of local guidelines and variations in recommendations by existing guidelines result in inconsistent management of these conditions in Thailand.
Kongwattanakul K, Jatavan P, Musigavong O, Pranpanus S, Salang L, Satirapod C, Petyim S, Uerpairojkit B.   +7 more
europepmc   +2 more sources

Short‐term cyclosporin A treatment improves pregnancy outcomes in patients with unexplained pregnancy loss: A prospective, open‐label, observational study

Clinical and Translational Discovery, 2022
Background Various treatments to improve live birth rate in women suffering unexplained recurrent pregnancy loss (URPL) have proven ineffective. Cyclosporin A (CsA), an immunosuppressant widely used in organ transplantation, can induce maternal–foetal ...
Mei‐Rong Du, Ming‐Qing Li, Wen‐Jie Zhou, Da‐Jin Li   +3 more
doaj   +1 more source

Dydrogesterone and norethisterone regulate expression of lipoprotein lipase and hormones-sensitive lipase in human subcutaneous abdominal adipocytes [PDF]

, 2007
Aim: In premenopausal women, hyper-androgenicity is associated with central obesity and an increased cardiovascular risk. We investigated the effects of dydrogesterone (DYD)(a non-androgenic progestogen) and norethisterone (NET)(an androgenic progestogen)
Barnett, A. H., Kumar, Sudhesh, McGee, K. C., McTernan, P. G., Palin, S. L., Sturdee, D. W.   +5 more
core   +1 more source

A randomized double-blind controlled trial of the use of dydrogesterone in women with threatened miscarriage in the first trimester: study protocol for a randomized controlled trial [PDF]

, 2016
BACKGROUND: Miscarriage is a common complication of pregnancy occurring in 15-20 % of all clinically recognized pregnancies. Currently, there is still no good scientific evidence to support the routine use of progestogens for the treatment of ...
Chan, MKD, Cheung, KW, Lee, VCY, Li, RHW, Ng, EHY, Yung, SF   +5 more
core   +1 more source

Oral dydrogesterone as an adjunctive therapy in the management of preterm labor: a randomized, double blinded, placebo‐controlled trial

BMC Pregnancy and Childbirth, 2021
Background Preterm birth is a major challenge in obstetric and perinatal care. It is the leading cause of neonatal death. The primary aim of this study was to evaluate the efficacy of oral dydrogesterone on latency period in managing preterm labor.
Suparudeewan Thongchan, Vorapong Phupong
doaj   +1 more source